Patent · US Active

Compositions comprising multivalent synthetic ligands of surface nucleolin and glycosaminoglycans

US9487559B2 · kind B2 · utility

0Cited by
15References
17Claims
0Family size

Assignees

Inventors

Key dates

Filing dateOct 4, 2011
Grant dateNov 8, 2016
Priority date
Expiry dateOct 4, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a composition comprising a Nucant multivalent synthetic compound and a glycosaminoglycan, the admixture of both compounds forming microspheres comprising both compounds, as well as their use for the treatment or prevention of diseases associated with deregulation of proliferation and/or angiogenesis, such as cancer, inflammatory disease, or for promoting wound healing.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.